Scientists create tailored drug for aggressive breast cancer
Scientists have used breast cancer cells' weakness against themselves by linking a tumor-selective antibody with a cell-killing drug to destroy hard-to-treat tumors.
May 22, 2024
0
52
Skin and Connective Tissue Diseases: News and Research on Triple Negative Breast Neoplasms
MeSH tree: C17.800.090.500.788
Study finds lower relapse risk in triple-negative breast cancer with high immune cell levels
Women with triple-negative breast cancer, and high levels of immune cells in the tumors, have a lower relapse risk after surgery, even without chemotherapy, according to a recent study published in JAMA.
Apr 17, 2024
0
66
Tumor biology may underlie racial differences in certain breast cancer outcomes
Regardless of socioeconomic factors and tumor variables, Black women with triple negative breast cancer have a significantly poorer response to chemotherapy than white women, researchers at Duke Cancer Institute report.
Feb 26, 2024
0
31
Targeting annexin-A1 can halt cancer cell growth, study finds
A new study published in Oncogene highlights the effectiveness of MDX-124, the first therapeutic drug to target annexin-A1, a protein that is overexpressed in several cancer types and promotes tumor progression.
Jan 19, 2024
0
53
Early life gene epimutation may contribute to breast cancer development
Research reveals that around 20 percent of all cases of the most severe form of breast cancer may arise from the small group of normal tissue cells carrying an epimutation of a specific gene.
Dec 7, 2023
0
32
Progress in the fight against resistance in metastatic breast cancer
A team of researchers at the Medical University of Vienna has discovered that dormant tumor cells surviving chemotherapy can be targeted through the inhibition of a specific protein called P-glycoprotein (P-gp). This discovery ...
Oct 2, 2023
0
39
Combination radiation with immunotherapy shows promise against 'cold' breast cancer tumors
Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two types of immunotherapy—one that boosts T cells, and another that boosts dendritic cells—can control tumors in preclinical models ...
Sep 25, 2023
0
98
Profiling gene messages could guide chemotherapy for triple-negative breast cancer
A new study sheds light on the genetic messages encoded by genes within "triple-negative" breast cancers—and poses important questions on how they could be better treated in future.
Aug 14, 2023
0
42
Research unveils genetic characteristics and improved prognosis of triple-negative apocrine carcinoma
Breast cancer research has taken a significant stride forward as Professor Semin Lee and his research team from the Department of Biomedical Engineering at UNIST, in collaboration with Professor Ji-Yeon Kim and Professor ...
Aug 14, 2023
0
29
A novel strategy to suppress triple negative breast cancer growth
In 2022, a team of researchers at Baylor College of Medicine discovered that a little-known enzyme called MAPK4 is involved in the growth of triple negative breast cancer (TNBC) and its resistance to certain therapies. Looking ...
Aug 2, 2023
0
61
